Back

Echocardiographic evolution of symptomatic patients with obstructive hypertrophic cardiomyopathy treated with mavacamten: experience of a portuguese terciary care center

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease - hypertrophic cardiomyopathy (4) Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Jose Miguel Viegas

Hospital de Santa Marta, Lisbon (Portugal)

1 More presentation in this session

Presentation thumbnail
Assessing the diagnostic value of right ventricular strain and thickness in the differential diagnosis of Fabry cardiomyopathy and hypertrophic cardiomyopathy
Doctor E. Mata (Creixomil, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in myocardial disease - hypertrophic cardiomyopathy (4)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Mavacamten use in a real-world cohort of obstructive hypertrophic cardiomyopathy patients: insights from the initial centre experience
thumbnail
Congress Presentation
Reduction of >100 mmHg left ventricular outflow tract gradients in obstructive hypertrophic cardiomyopathy during mavacamten treatment already after one week of treatment
thumbnail
Congress Presentation
Assessment of changes in right-sided cardiac echocardiographic parameters in obstructive hypertrophic cardiomyopathy during mavacamten treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources